Medical Pharmacology Chapter 16:  Pharmacology of Antipsychotics Drugs

Clinical Cases

• Case 4: Negative symptoms and functional outcome

  • A 24‑year‑old man with a first‑episode of schizophrenia 18 months ago has had good control of hallucinations and delusions on a low‑dose second‑generation antipsychotic.

    • He has not been hospitalized in the last year. However, he spends most of his time at home, rarely initiates conversation, and dropped out of college.

    • He says he “just doesn’t feel like doing anything” and “nothing seems fun.”

    • His mother reports he needs prompting for basic hygiene.

    • There is no clear depressed mood, guilt, or suicidal ideation.

    • Questions

      • What symptom domain is now most functionally impairing for him?

      • How would you clinically distinguish primary negative symptoms from depression and medication side effects?

      • Why are these symptoms so important for his long‑term prognosis, even though his positive symptoms are controlled?

      • What types of interventions (broad categories) could help address his deficits?

    • Explained answers

      • Most impairing domain

        • He exhibits prominent negative symptoms: avolition, anhedonia, alogia, and social withdrawal, with impaired role functioning and self‑care.

        • Positive symptoms are largely controlled, so functional impairment is being driven by this negative/cognitive domain.

      • Distinguishing negative symptoms from depression or side effects

        • Depression: look for pervasive sadness, guilt, hopelessness, marked diurnal variation, suicidal ideation where are not clearly present here.

          • In depression, patients often report distress about their low energy; in primary negative symptoms, there may be less subjective distress.

        • Medication side effects: evaluate for akinesia, extrapyramidal symptoms, sedation, or parkinsonism; use rating scales if needed and consider dose reduction or switching if EPS or sedation are prominent.

        • Primary negative symptoms persist despite optimized medication, minimal EPS, and absence of significant depressive features. Longitudinal observation helps: if these deficits preceded treatment and have remained relatively stable, they are more likely primary.

      • Prognostic importance

        • Negative and cognitive symptoms are among the strongest predictors of functional outcome (employment, independent living, social relationships) in schizophrenia and FEP.

        • Even with full positive symptom remission, persistent negative symptoms markedly reduce the likelihood of functional recovery, and they are harder to treat pharmacologically than positive symptoms.

      • Intervention types

        • Psychosocial:

          • Cognitive remediation and social skills training to improve cognitive and social functioning.

          • Behavioral activation and structured activity scheduling.

          • Supported employment/education (e.g., IPS) to scaffold return to roles.

        • Pharmacologic:

          • Optimize antipsychotic regimen to minimize sedation/EPS.

          • Consider agents with some evidence for negative symptoms in selected cases, though effects are modest.

          • Family involvement: psychoeducation so family supports realistic goals and avoids high expressed emotion, which can worsen motivation and engagement.

           

DISCLAIMER